|
tbar.gif
Click
here to
submit entries
|
|
|
China
Says Importing Countries Bear Responsibility for Drug Checks
|
February
27, 2008--China’s
State Food and Drug Administration said checks of drug ingredients made in
China are ultimately the responsibility of the importing countries. It
remains unclear if the heparin supplied by the Chinese firm Changzhou SPL
is connected to the adverse reactions linked to Baxter International’s
drug sold in the US. The US FDA never inspected Changzhou SPL’s plant
due to a mix-up; China’s State Food and Drug Administration never
inspected the plant because it was registered as a chemical company, not
as a pharmaceutical manufacturer. The
Wall Street Journal (Subscription required)
See related WSJ articles: Legislators
Review Inspection Policy Amid Heparin Fallout (2/22); China’s
Role in Supply of Drug is Under Fire (2/21)
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
